Exact Mass: 367.1314

Exact Mass Matches: 367.1314

Found 75 metabolites which its exact mass value is equals to given mass value 367.1314, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

EMTDB

N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide

C19H20F3NO3 (367.1395)


   

4-[(2-Cyclobutylimidazo[4,5-b]pyrazin-3-yl)methyl]-7,8-difluoro-1H-quinolin-2-one

4-({2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl}methyl)-7,8-difluoro-1,2-dihydroquinolin-2-one

C19H15F2N5O (367.1245)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

Riodipine

3,5-Dimethyl 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid

C18H19F2NO5 (367.1231)


   
   

Maybridge3_007620

Maybridge3_007620

C20H21N3O2S (367.1354)


   
   

1-[4-Hydroxy-6-[2-(dimethylamino)ethyl]benzothiazole-2-yl]-3,4-dihydroisoquinoline-6-ol

1-[4-Hydroxy-6-[2-(dimethylamino)ethyl]benzothiazole-2-yl]-3,4-dihydroisoquinoline-6-ol

C20H21N3O2S (367.1354)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

tris-(1-Benzotriazolyl)methane

tris-(1-Benzotriazolyl)methane

C19H13N9 (367.1294)


   
   

Boc-L-glutamine p-nitrophenylester

Boc-L-glutamine p-nitrophenylester

C16H21N3O7 (367.1379)


   

(2S)-2-amino-5-(diaminomethylideneamino)-N-(4-methyl-2-oxochromen-7-yl)pentanamide,hydrochloride

(2S)-2-amino-5-(diaminomethylideneamino)-N-(4-methyl-2-oxochromen-7-yl)pentanamide,hydrochloride

C16H22ClN5O3 (367.1411)


   
   

Riodipine

Riodipine

C18H19F2NO5 (367.1231)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

Edoxaban impurity 6

Edoxaban impurity 6

C16H22ClN5O3 (367.1411)


   

N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[(2-methoxyphenyl)azo]-3-oxobutyramide

N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[(2-methoxyphenyl)azo]-3-oxobutyramide

C18H17N5O4 (367.128)


   

beta-lactosyl azide

beta-lactosyl azide

C12H21N3O10 (367.1227)


   
   

3-[[(2,3-dimethylanilino)-sulfanylidenemethyl]amino]-1H-indole-2-carboxylic acid ethyl ester

3-[[(2,3-dimethylanilino)-sulfanylidenemethyl]amino]-1H-indole-2-carboxylic acid ethyl ester

C20H21N3O2S (367.1354)


   

(2R)-3-{[1-(5,6-dihydropyridin-2-yl)-2-hydroxy-2-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}ethyl]sulfanyl}-2-acetamidopropanoate

(2R)-3-{[1-(5,6-dihydropyridin-2-yl)-2-hydroxy-2-{3-[(1E)-prop-1-en-1-yl]oxiran-2-yl}ethyl]sulfanyl}-2-acetamidopropanoate

C17H23N2O5S- (367.1328)


   
   

4-[4-(Benzenesulfonyl)-1-piperazinyl]-2-methylquinoline

4-[4-(Benzenesulfonyl)-1-piperazinyl]-2-methylquinoline

C20H21N3O2S (367.1354)


   

1-(4-Morpholinyl)-2-[2-(phenylmethylthio)-1-benzimidazolyl]ethanone

1-(4-Morpholinyl)-2-[2-(phenylmethylthio)-1-benzimidazolyl]ethanone

C20H21N3O2S (367.1354)


   

6-(4-morpholinyl)-3-(2-phenylethyl)-2-sulfanylidene-1H-quinazolin-4-one

6-(4-morpholinyl)-3-(2-phenylethyl)-2-sulfanylidene-1H-quinazolin-4-one

C20H21N3O2S (367.1354)


   

4-Hydroxybenzoic acid [2-[1-(2-fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester

4-Hydroxybenzoic acid [2-[1-(2-fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester

C21H18FNO4 (367.122)


   

2-Hydroxy-17beta-estradiol 3-sulfate

2-Hydroxy-17beta-estradiol 3-sulfate

C18H23O6S- (367.1215)


   

4-[3-[[4-(4-fluorophenyl)-1-piperazinyl]-oxomethyl]-2H-isoxazol-5-ylidene]-1-cyclohexa-2,5-dienone

4-[3-[[4-(4-fluorophenyl)-1-piperazinyl]-oxomethyl]-2H-isoxazol-5-ylidene]-1-cyclohexa-2,5-dienone

C20H18FN3O3 (367.1332)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

N-hydroxydebrisoquine O-glucuronide

N-hydroxydebrisoquine O-glucuronide

C16H21N3O7 (367.1379)


   

N-(3-methylbut-2-en-1-yl)-2-sulfanyladenosine

N-(3-methylbut-2-en-1-yl)-2-sulfanyladenosine

C15H21N5O4S (367.1314)


   
   

APTO-253

APTO-253

C22H14FN5 (367.1233)


APTO-253 (LOR-253) is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253 mediates anticancer activity through induction of the Krüppel-like factor 4 (KLF4) tumor suppressor[1][2]. APTO-253 has antiarthritic activity[3].

   

8-{[2-(dimethylamino)ethyl]sulfanyl}-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),4,6,8,10,12,14,16-octaene-6,15-diol

8-{[2-(dimethylamino)ethyl]sulfanyl}-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),4,6,8,10,12,14,16-octaene-6,15-diol

C20H21N3O2S (367.1354)


   

8-{[2-(dimethylamino)ethyl]sulfanyl}-6-hydroxy-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),5,7,9,11,13,16-heptaen-15-one

8-{[2-(dimethylamino)ethyl]sulfanyl}-6-hydroxy-4,11-diazatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadeca-1(18),5,7,9,11,13,16-heptaen-15-one

C20H21N3O2S (367.1354)